NCT03265470View on ClinicalTrials.gov

Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

March 30, 2020

Study Completion Date

August 30, 2020

Conditions
Radical Cystectomy
Interventions
DRUG

Dexmedetomidine

Patients will receive Loading dose of dexmedetomidine (0.8μg/kg) over 20 minutes, followed by intravenous infusion (0.4μg/kg/h) during intra-operative period till end of procedure.

DRUG

Fentanyl

Patients will receive Loading dose of fentanyl (1μg/kg), followed by intravenous infusion (1μg/kg/h) during intra-operative period till end of procedure.

Trial Locations (1)

050

Mansoura university, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03265470 - Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy | Biotech Hunter | Biotech Hunter